Next Article in Journal
Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking
Previous Article in Journal
GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(7), 824; https://doi.org/10.3390/ph15070824
Action Date Notes Link
article xml file uploaded 2 July 2022 12:36 CEST Original file -
article xml uploaded. 2 July 2022 12:36 CEST Update -
article pdf uploaded. 2 July 2022 12:36 CEST Version of Record https://www.mdpi.com/1424-8247/15/7/824/pdf-vor
article supplementary file uploaded. 2 July 2022 12:36 CEST - https://www.mdpi.com/1424-8247/15/7/824#supplementary
article html file updated 2 July 2022 12:37 CEST Original file -
article xml file uploaded 4 July 2022 15:00 CEST Update -
article xml uploaded. 4 July 2022 15:00 CEST Update -
article pdf uploaded. 4 July 2022 15:00 CEST Updated version of record https://www.mdpi.com/1424-8247/15/7/824/pdf-vor
article html file updated 4 July 2022 15:01 CEST Update -
article xml file uploaded 4 July 2022 15:10 CEST Update -
article xml uploaded. 4 July 2022 15:10 CEST Update https://www.mdpi.com/1424-8247/15/7/824/xml
article pdf uploaded. 4 July 2022 15:10 CEST Updated version of record https://www.mdpi.com/1424-8247/15/7/824/pdf
article html file updated 4 July 2022 15:11 CEST Update -
article html file updated 12 August 2022 23:57 CEST Update https://www.mdpi.com/1424-8247/15/7/824/html
Back to TopTop